 is among the world’s leading suppliers of medical devices. BD
built the first-ever manufacturing facility in the U.S. to produce syringes and needles in 1906 and has been the leading innovator in injection- and infusion-based drug delivery ever since.
Principal product lines include needles, syringes and intravenous catheters for medication delivery; insulin injection devices and blood glucose monitors for treatment of diabetes; prefillable drug delivery devices provided to pharmaceutical companies and sold to end-users as drug/device combinations; surgical blades and regional anesthesia needles; critical care monitoring devices; ophthalmic surgery devices; sharps disposal containers; and home healthcare products such as ACE brand elastic bandages.
|
|
 |
 |
BD Medical’s business strategy is focused on effectively addressing four global health needs:
Reducing the spread of infection…with an extensive line of safety-engineered devices to reduce the risk of sharps injuries to healthcare workers around the world–a field in which BD is a global leader. BD Medical provides innovative IV flush syringes and closed IV catheter systems that enhance patient safety by reducing the potential for contamination and improve healthcare worker safety by eliminating needles. BD Medical also offers low cost, auto-disable immunization and curative injection devices to prevent disease spread associated with syringe reuse in developing countries.
Enhancing diabetes treatment…with devices for insulin injection and blood glucose monitoring. BD developed the first syringe dedicated to insulin delivery in 1924 and has made continuous advances ever since. Today’s insulin injection needles are tiny and virtually pain-free, and insulin injection offers precise dose control leading to tighter control of blood glucose levels. BD Medical’s blood glucose monitoring systems offer leading-edge performance, with tiny sample sizes and fast read times, as well as radio frequency interface with the “smart“ MiniMed Paradigm® insulin pumps from Medtronic Diabetes.
Advancing drug delivery…The category leader in prefillable devices, BD works with more than 100 pharmaceutical companies. Injectable drugs sold in a prefilled syringe format reduce the potential for medication error and contamination while providing drug companies with a means to differentiate their offering. For future implementation, BD is developing Advanced Drug Delivery platforms that potentially offer important therapeutic advantages versus conventional injection methods.
Improving ophthalmic surgery outcomes…through new technologies that dramatically enhance blade sharpness while protecting ophthalmic surgeons and their staffs from occupational injury. BD Medical offers cataract blades and cannulas, as well as ophthalmic accessories. Strategic investments in innovative solutions to other ophthalmic medical needs hold the potential for future growth in this field.
 |
 |
 |
 |
The BD Hypak prefilled syringe with BD Preventis automatic needle shielding system is the most widely used safety system for prefilled syringes in the U.S.
|
The new BD SoloMed syringe is intended for acute care hospitals in developing countries. A simple push following drug delivery breaks the plunger, preventing reuse. A safety-shielded version helps protect clinicians from needlestick injury.
|
BD PosiFlush Saline and Heparin Lock Flush Syringes help protect patients and clinicians alike by eliminating needles. These devices are manufactured and filled by BD using an automated process.
|
The BD Logic Blood Glucose Monitor offers the combination of best-in-class features–fast 5-second test results, the smallest blood sample, and less painful testing due to using the thinnest lancets.
|
|
|
